WINDTREE THERAPEUTICS INC /DE/ (WINT): Nasdaq/NYSE listing notice — Windtree receives Nasdaq bid price deficiency letter; delisting risk if hearing not granted by June 25

WINDTREE THERAPEUTICS INC /DE/

Nasdaq notified Windtree on June 18, 2025 that closing bid price has been below $1.00 for 30 consecutive days.
Company is ineligible for standard 180-day compliance period due to two reverse stock splits >250:1 over prior two years.
Windtree must request a hearing by June 25, 2025, or face suspension/delisting from Nasdaq.
Company intends to request a hearing; automatic stay of delisting pending hearing and any extension granted by Panel.
Common stock continues trading under symbol WINT; no assurance of regaining compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv), 5815(4)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)(iv), 5815(4)(A)

Exact text from the filing

June 18, 2025, Windtree Therapeutics, Inc. (the “ Company ”) received a deficiency letter (the “ Bid Price Deficiency Letter ”) from the Nasdaq Listing Qualifications Department (the “ Staff ”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“ Minimum Bid Price Requirement ”). Normally, a company would be afforded a 180-cal

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-25-020949

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.